Delivery Order SPE2DR25D2104-SPE2DR26F3NFF
- Not listed
- On June 2, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $7,350.24 to AmerisourceBergen Drug Corp for the supply of Nucynta (tapentadol) 50 mg tablets in quantities of 100. This firm fixed-price delivery order, with an ultimate completion date of June 3, 2025, represents a continuation of the company's extensive pharmaceutical support to the Department of Defense medical procurement system. The award is non-competitive with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Nucynta (tapentadol) 50 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order with a ceiling value of $1,225.04 and an ultimate completion date of August 6, 2025. The award represents a non-competitive action under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nucynta (tapentadol) 100 mg tablets in a quantity of 100 units under a firm fixed-price contract. The order, issued on October 22, 2025, carries a ceiling value of $4,550.07 with an ultimate completion date of October 23, 2025. This non-competitive delivery order represents a routine pharmaceutical procurement supporting military and federal healthcare needs. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Nucynta (tapentadol) 50 mg tablets in quantities of 100 units, with a ceiling value of $1,225.04. This firm fixed-price delivery order is scheduled for completion by July 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Nucynta (tapentadol) 100 mg tablets in quantities of 100 units, with a ceiling value of $1,908.20. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an open procurement process. The order is set to be completed by October 31, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Nucynta (tapentadol) 100 mg tablets in a quantity of 100 units, with a contract ceiling value of $1,972.30. This is a firm fixed-price delivery order with an ultimate completion date of October 23, 2025, and was not issued under a set-aside program. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Nucynta ER (tapentadol extended-release) 100mg tablets, valued at $6,005.43. This firm fixed-price delivery order, which represents a child contract under a larger vehicle, is scheduled for completion by August 5, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award was made through open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Nucynta (tapentadol) 100 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order valued at $12,347.38 with an ultimate completion date of October 28, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Nucynta (tapentadol) 50 mg tablets in quantities of 100 units, with a ceiling value of $1,225.04. This firm fixed-price delivery order, which must be completed by August 12, 2025, represents a competitive award with no set-aside designation and will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen...
- The Defense Logistics Agency awarded a $1,522.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Nucynta (tapentadol) 50 mg tablets in quantities of 100. This is a non-set-aside contract with a completion date of September 26, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving critical federal medical procurement...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3NFFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Nucynta (tapentadol) 50 mg tablets in quantities of 100, valued at $2,251.72. This firm fixed-price delivery order is not set-aside and will be completed by November 5, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply needs, specifically for pain management medication. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor contract enables the pharmaceutical distributor to supply a wide range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare systems globally. AmerisourceBergen's significant federal contract portfolio demonstrates the company's established capability to meet competitive federal procurement requirements and serve critical defense and veteran healthcare missions through flexible contracting vehicles designed to streamline pharmaceutical supply chains across the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 11/4/25 |